SPL 1.04% 9.7¢ starpharma holdings limited

Ann: Starpharma commences phase 1/2 DEP irinotecan trial

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.